aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Nov 10, 2015 · 10-Q · 41 days after period end · 0001564590-15-010357
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Net Income | -$11.33M | -$6.63M |
| EPS Diluted | -$0.48 | -$8.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 10, 2015 · 41 d after period end
